A New Era of Weight Management is Coming to Hims & Hers
1 Ozempic is not FDA-approved for weight loss. Providers may, in their clinical discretion, prescribe it off-label if…
Unused medication to be reused under new EU legislation
The Netherlands supports European legislation currently being drafted which will allow unused medication to be returned to pharmacies…
Schoolchildren in Verulam, Chatsworth and Phoenix are misusing prescription drugs and cough syrups to get high
CONCENTRATION Yoshini Perumal|Published 1 day ago COMMUNITY leaders in Chatsworth, Phoenix and Verulam are sounding the alarm over…
Aidan Shepherd On Chiropractic Career
[Written by Stephen Wright] Dr Aidan Shepherd’s route from semi-professional football in England into chiropractic care on the…
Why people take it and what health experts say
Organic remedies often compete for the title of best solutions for healthy bodies. This season, Ginger shots have…
TrumpRx isn’t doing much for drug prices. What would it take to change that?
Americans are furious about drug prices. The Trump administration’s answer? A new website. But more than a month…
Is the ‘Ozempic era’ an opportunity for no-and-low?
With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden asks whether the…
Public warned against consuming 4 products after reported adverse effects
SINGAPORE – The Health Sciences Authority (HSA) has cautioned the public against consuming four products that were found…
Medicine shortages warning after Iran blockades Strait of Hormuz
Many common drugs, including aspirin, paracetamol, ibuprofen and a range of antibiotics, rely on ingredients sourced from the…
What to Know about the Experimental GLP-1 Drug CagriSema
3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…
Legislation would end tax breaks on prescription drug commercials
Drug companies in Maryland can deduct the cost of commercials for prescription drug medications as a business expense,…
India’s Zydus, Lupin sign deal to co‑market Semaglutide injections
March 17 (Reuters) – Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on…